Leorah Kroyanker

Title: Leorah Kroyanker: Innovator in Pharmaceutical Compositions

Introduction

Leorah Kroyanker is a notable inventor based in Jerusalem, Israel. She has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for various types of cancer. Her innovative work focuses on the use of verotoxins in medical applications.

Latest Patents

Leorah Kroyanker holds a patent for "Verotoxin pharmaceutical compositions and medical treatments therewith." This patent describes pharmaceutical compositions that include known verotoxins, specifically verotoxin 1 and its pentameric subunit B. These compositions have been found to be effective in treating mammalian neoplasia, including brain cancer, ovarian cancer, breast cancer, and skin cancer. Although verotoxin 1 has demonstrated anti-neoplastic activity in vitro, non-lethal doses have shown therapeutic potential in vivo. The use of sensitizers, such as sodium butyrate, enhances the efficacy of these verotoxins and their subunit B.

Career Highlights

Throughout her career, Leorah Kroyanker has focused on advancing medical treatments through innovative pharmaceutical compositions. Her research has the potential to significantly impact cancer treatment and improve patient outcomes.

Collaborations

Leorah has collaborated with esteemed colleagues in her field, including Clifford A Lingwood and Richard C Hill. These collaborations have contributed to the development and validation of her innovative pharmaceutical compositions.

Conclusion

Leorah Kroyanker's work in the field of pharmaceuticals exemplifies the impact of innovative thinking on medical treatments. Her contributions to cancer therapy through the use of verotoxins highlight the importance of research and collaboration in advancing healthcare solutions.